SIC 3841 – Surgical and Medical Instruments and Apparatus
| Valuation | |
|---|---|
| Market Cap ($M) | 6.06 |
| Enterprise Value ($M) | 7.63 |
| Book Value ($M) | -0.58 |
| Book Value / Share | -0.13 |
| Price / Book | -10.41 |
| NCAV ($M) | -3.42 |
| NCAV / Share | -0.77 |
| Price / NCAV | -1.77 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | 2.10 |
| Return on Assets (ROA) | 0.63 |
| Return on Equity (ROE) | n/a |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 1.20 |
| Current Ratio | 1.34 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 11.65 |
| Assets | 14.49 |
| Liabilities | 15.08 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 46.93 |
| Operating Income | 8.11 |
| Net Income | 6.70 |
| Earnings Per Share Basic And Diluted | n/a |
| Earnings Per Share Diluted | n/a |
| Earnings Per Share Basic | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | 4.65 |
| Cash from Investing | -0.88 |
| Cash from Financing | -5.81 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G/A | Singer Douglas Mark | 4.44 | -21.70 | |
| 13D/A | 1315 Capital II, L.P. | 68.00 | 197.03 | |
| 13D/A | Ampersand 2018 Limited Partnership | 76.00 | 197.03 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K/A Amendment No. 1 | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
(click for more detail) |
||
| Similar Companies | |
|---|---|
| HDII – Hypertension Diagnostics, Inc. | HLTT – Healthtech Solutions Inc. |
| HRGN – Harvard Apparatus Regenerative Technology Inc. | INLB – Item 9 Labs Corp. |
| IONM – Assure Holdings Corp. |